A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : DTaP-IPV / diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine

[Related PubMed/MEDLINE]
Total Number of Papers: 7
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   DTaP-IPV  (>> Co-occurring Abbreviation)
Long Form:   diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 A second dose of a measles-mumps-rubella vaccine administered to healthy four-to-six-year-old children: a phase III, observer-blind, randomized, safety and immunogenicity study comparing GSK MMR and MMR II with and without DTaP-IPV and varicella vaccines co-administration. MMR
2019 Post-marketing surveillance to assess the safety and tolerability of a combined diphtheria, tetanus, acellular pertussis and inactivated poliovirus vaccine (DTaP-IPV) in Korean children. ADRs, AEs, PMS, SAEs
2017 Elevated Immune Response Among Children 4 Years of Age With Pronounced Local Adverse Events After the Fifth Diphtheria, Tetanus, Acellular Pertussis Vaccination. AEs, IL, Th2
2014 Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine. VSD
2012 Persistence of antibody response following a booster dose of Hib-MenC-TT glycoconjugate vaccine to five years: a follow-up study. GMCs, Hib
2011 Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea. FHA, PT
1999 Immunogenicity and safety of a tetravalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine. ---